www.pnarmacyprep.

com

PhsrmacvPrep.cam

C a l c u l a t i oann d M e d i c i n aCl h e m i s t rTv e s t

1 "H. o wm a n yg r a m so f c h e m i c aal r er e q u i r e dt o m a k e1 2 0m l o f a 2 0 %w / w o f s o l u t i o no f a s p .
g r a v i t y1 . 1 5 ?

a)1209 B)2Bg C)138g D)20g E)18e

2 ) G i v e na R xa n dt h e s i g n a t u r ies :S t a r t4 0 m ga n dd e c r e a s5em ge v e r yd a yu n t i lf i n i s h H
. ow
m a n yd a y st h e p a t i e nw
t i l l t a k et o f i n i s ht h i s R x .

A)Bdays B )7 d a y s C )6 d a y s D )5 d a y s E )4 d a y s

3 . P h a r m a cm s s t o c ks o l u t i o no f 1 , : 7 5 a0 n dw o u l dl i k ey o ut o p r e p a r e6 0 m l so f
y a n a g epr r o v i d e a
1 : 1 0 . 0 0 0h,o w m u c hy o u n e e dt o u s eo f t h e s t o c ks o l u t i o n ?

A)2.4mls . .B )4 . 6 m l s C )1 . 3 m l s D )4 6 m l s E )0 . 4 6 m l s

4 . P h a r m a cmya n a g eprr o v i d eadl c o h o9[5 %a n da s k e tdo p r e p a r6e0 m o . o wm u c ho f

l f a l c o h oLl 2 %H
a l c o h o9l 5 % y o us h o u l du s e dt o m a k et h i sn e w c o n c e n t r a t i oonf a l c o h o l ?

a)4.32m1 b )7 . 5 7 m i c)8.64m1 d)6.0m1 e)6.57m1

managerprovidedyou ZnClz0.7%,phenilephrine
5. Pharmacy 01% andboricacid1.1%with Evalues
0 . 1 - 6 , 0 . 3a2n d0 . 5 r e s p e c t i v e T
l yh. i ss o l u t i o nw i l l b e :

a) lsotonic b) Hypertonic c) Hypotonic d) lso-osmotice) lsotonicity

cannotbe finding.

6. A patientbroughta prescription with the followingsignature: Startwith doubledoseof 5ml,than take

. o wm a n ym l o f a m o x i c i l l isnu s p e n s i osnh o u l db e d i s p e n s etdo t h i sp a t i e n t :
2 . 5 m l sB I Df o r T d a y s H

a )3 0 m l s b )3 5 m l s c)40mls d)45mls e)50mls

7. Rx;Prednisone
5mg

S t a r t 4 O m g a n d d e c r e a s e5 r n g e v e r y d a y u n t i l f i n i s h .

l l o w m a n y t a b l e t ss h o u l db e d i s p e n s e d ?

a) 30 tablets b)35 tablets c) 36 tablets d)40 tablets e) 12tablets

8 . A m e t e r e d d o s e i n h a l e rc o n t a i n sl - 2 0d o s e s .H o w m a n y d a y st h e p a t i e n tw i l l t a k e t o f i n i s ht h e e n t i r e
i n h a l e rw i t h t h i s s i g n a t u r e": U s e 2 i n h a l e r si n e a c h n o s t r i le v e r ym o r n i n g a n d a t b e d t i m e "

C o p y r i g h@t 2 O O O - 2 0T n f t h i s m a n u a il s s t r i c t l yp r o h i b i t e da n d i t i s i l l e g a l
1 I2P SI n c .U n a u t h o r i z erde p r o d u c t i o o
t o r e p r o d u c ew i t h o u t p e r m i s s i o nT.h i sm a n u a il s b e i n gu s e dd u r i n gr e v i e ws e s s i o ncso n d u c t e db y P h a r m a c y -
Preo.
 www.pharmacyprep.com

a) 7 days b) 10 days c) 20 days d) 15 days e) 30 days

Ans:D "Two inhalersin eachnostrileverymorningand at bedtime,,

2 x 2nostril x 2(morning+night)=gdosesdaily

120 doses+ 8 dosesdaily= 15 dayssupply

9 ' w h a t i s t h e m i n i m u mq u a n t i t yt h a t c a nb e w e i g h to n a b a l a n c e
w i t h s e n s i t i v i trye q u i r e m e n tosf 1 5 m g
of a 5% error is permissible

a)100mg b)200mg c)300mg d)400mg e)5oOmg

10' what is the sensitivity

of a balancethat canweight l2omgof a substance
and hasa permissible
er-
ror of 5%o?

a)6mg b)16mg c)66mg d) 26mg e) 1.6mg

11' Pyridineis a mono heterocyclic compoundvery importantin the activityof manydifferentdrugs.

w h i c h o f t h e f o l l o w i n gd r u go x i d i z e fdr o m t h e m o l e c u l asr t r u c t u r e1 , 4 - d i h y d r o p y r i d i n e
t o p y r i d i n er i n g ?

a )V e r a p a m i l b ) D i g o x i n c)Cronidine d) Nifedipine e) Dirtiazem

1 2 .Q u i n o l o n e
structure
m a y b e f o u n di n w h i c ho f t h e f o l l o w i n gs u b s t a n c e s ?

a ) V i t a m iK
n

b)Thiamine

c)Cyanocobalamin

d ) F o l i ca c i d

e ) V i t a m i nA

1 3 ' W h i c ho f t h e f o l l o w i n gp r e p a r a t i oanr eu s i n gt r a n st r e t i n o i ni s a n i s o m e ro f c a r o t e n e s .

A)oraltretinoins B ) t o p i c a l t r e t i n o i n s C )o r a l a n d t o p i c ab lo t h p r e p a r a t i o nDs) a l l o f t h e a b o v e

1 4 ' A n u r s e b r i n g sa p r e s c r i p t i o nt o t h e h o s p i t a lp h a r m a c ya s k i n gt h e p h a r m a c i s t
how to pre-
p a r e t h e f o l l o w i n gp r e s c r i p t i o nf o r a 1 5 5 l b p a t i e n t :

R x : D o p a m i n e2 0 0 m gi n 5 0 0 m l s o l u t i o n

lnject Sug/kglmin

c o p y r i g h t @ 2 0 0 0 - 2 0 1 2T I P Sl n c . U n a u t h o r i z e dr e p r o d u c t i o n o f t h i s m a n u a l
i s s t r i c t l y p r o h i b i t e da n d i t i s i l l e g a l
t o r e p r o d u c ew i t h o u t p e r m i s s i o nT- h i s m a n u a li s b e i n g u s e d d u r i n g r e v i e w
s e s s r o n cs o n d u c t e db v p h a r m a c v -
Prep.
 www.pnarmacyprep.com

T h e n u r s en e e d s t o k n o w t h e r a t e / m li n w h i c h s h e s h o u l di n f u s e t h em e d i c a t i o nW
. h i c ho f t h e
f o l l o w i n gc o n c e n t r a t i o no f t h e d r u g / m l s h o u l d b e i n f u s e d ?

a) 100pg/ml b) 200prg/ml c)300pg/mt d)aOOpglml e) 500pg/ml

15.We receivethe followingprescription:

Rx. Tetracaine1.0%

Boricacid 0.5%

Waterqs lOO% Dispense

60mlsophthalmicsolution.

How manymg of NaClis neededto adjustthe isotonicity

of this solution?

(Evaluesare 0.18for tetracaineand0.5 for boricacid)

a) 108mg b)77mg c ) 1 2 8m g d ) 7 1 8m g e ) 2 2 8m g

1 6 . T h ed o s eo f m o r p h i n et h a t a p a t i e n its r e c e i v i ndga i l yi s 3 0 m g( l t a b l e to f 1 5 m gB t D ) t. f s w i t c ht o
l i q u i dm o r p h i n e5 m g / m l a
, n dd o s ei s Q 4 h o u r sh, o w m u c hm o r p h i n es h o u l db e s u p p l i e df o r 2 0 d a y sp e -
riod,to providethe samereliefregimen?

a)6ml b)60ml c)120m1 d) 180mi e)200m

1 7 - H o w m a n y m i l l i l i t e r so f a 1 : 1 5 0 0s o l u t i o nd i s s o l v i n g4 . 8 g o f N a C Ii n w a t e r c a n m a k e ?
4-1000mL 8 - 1 5 0 0m L C-3500m1 D-72O0mL

1 8 . 1 0 0 m l o f 5 % w / v o f D i c l o f e n a ci n e t h a n o lw a s a d d e dt o 1 5 0 m l o f e t h a n o l .D e n s i t vo f E t h -
a n o l i s 0 . 8 . T h e % w / w o f D i c l o f e n a cg e l i n a l c o h o lw i l l b e :
a) 4.76%w/w
b) 1,.96%w/w
c) 3.92%w/w
d) 2.44%w/w

1 9 . 5 m l o f 1 ' O % w / v oaf d r u g w a s d i l u t e d f i v e t i m e s w i t h G l y c e r i n e ( DGolfy c e r i n e i s

1.259/ml).The concentrationw/w of the drug is:
a) 2.42%w/w
b ) 1 . 5 7% w / w
c) I.96%w/w
d ) N o n eo f t h e a b o v e

2 0 . 1 0 0 m 1o f 5 % w l v o f D i c l o f e n a ci n E t h a n o lw a s a d d e d t o 1 5 O m lo f e t h a n o l .D e n s i t vo f E t h a -
n o l i s 0 . 8 .f h e % w l w o f D i c l o f e n a cs e l i n a l c o h o lw i l l b e :

C o p y r i g hO
t 2 0 0 0 2 0 1 2T I P SI n c .U n a u t h o r i z erde p r o d u c t i o o
n f t h i s m a n u a li s s t r i c t l yp r o h i b i t e da n d i t i s i l l e g a l
to reproduce w i t h o u t p e r m i s s i o nT.h i sm a n u a il s b e i n gu s e dd u r i n gr e v i e ws e s s i o ncso n d u c t e db v p h a r m a c v
P r ep .
 www.pharmacyprep.com

A. 4.76% w/w
B. L.96%w/w
C. 3.92% w/w
D. 2.44% w/w

2 1 . 5 m l o f 1 , O % w / vo f a d r u g w a s d i l u t e df i v e t i m e s w i t h G l y c e r i n e( D e n s i t yo f G l y c e r i n ei s
1.25 g/ml). The concentrationw/w of the drug is:
A.2.42%w/w
B . 1 , . 5 7% w / w
C. 1..96%w/w
D . N o n eo f t h e a b o v e

a l c o h obl e p r e p a r e dh, o w m u c hl o w a l -
2 2 . A p h y s i c i a rne q u e s ttsh a t a n e l i x i rc o n t a i n i n g 3 2 %
c o h o el l i x i r ( 1 0 % a l c o haonl d) h i g h a l c o heol li x i r T B % m u s t b e m i x e d t o p r e p a r e l p i rnet -o f
q u e s t e de l i x i r .
A . 3 2 0m l a n d 1 5 3m l
B . 1 5 3m l a n d3 2 0m l
C . 3 2 0m l a n d3 2 0m l
D . 1 5 3m l a n d 1 5 3m l
22 partsof 78"h
78

)la

a''

\ 4 6 partsof 10%
10

A '
+/rX+O
Low alcohol :320ml
68

High alcohol 473 x 22 : 1 5 3m l

6 8 ' , ' '

2 3 . A h o s p i t acl l i n i cr e q u e s t 2s l b o i Z y "h y d r o c o r t i s o noei n t m e n t H

. o wm a n y g r a m so f
5 % h y d r o c o r t i s oonien t m e n tw o u l db e d i l u t e dw i t h w h i t e p e t r o l e u m t o p r e p a r et h i s o r d e r .
A . 3 6 3 . 3g r a m s (a
,t

B. 400 grams

C o p y r i g h@t 2 0 0 0 - 2 0 1 .T2I P SI n c .U n a u t h o r i z erde p r o d u c t i o n o f t h i s m a n u a l i s s t r i c t l y p r o h i b i t e d a n d i t i s i l l e g a l

e i t h o u tp e r m i s s i o T
t o r e p r o d u cw nh. i sm a n u ails b e i n g u s e d d u r i n g r e v i e w s e s s i o n sc o n d u c t e d b y P h a r m a c y -
Prep.
 www.pnarmacyprep.com

C. 463 grams
D . n o n eo f t h e a b o v e

2 4 . W h a t i s w e i g h t o f K C Ii n r h g i s n e e d e dt o p r o v i d e 1 0 9 m E q o f K * ?( M W : K = 3 9 ;C l = 3 5 . 5 ) :
A. 2.L29 'l
.,,-""!:
B. 4 . O Gg o'

C . 4 . 2 5g
D. 8.1.2 g

2 5 . R i n g e r ' sI n j e c t i o nc o n t a i n s8 0 6 g o f s o d i u m c h l o r i d ep e r l i t e r . H o w m a n y m E q ' ss o d i u m
d o e st h i s r e p r e s e n t ?N a C lI M W 5 8 . 5 9 ) . 1, , '
'*"
A. L4.7 \ r +' ::
t"E
B. 73.5
c. r3.7
D. 198

2 6 . H o w m a n y m E q o f c a l c i u ma r e t h e r e i n 1 0 m l o f I O % c a l c i u mg l u c o n a t es o l u t i o n ?( M W o f
C a g l u c o n a t ei s 4 4 8 , A t o m i c n u m b e r o f c a l c i u mi s 4 0 ) .
\ 1 i l
A . 0 . 4 5m E q
B . 2 . 2 3m E q
C . 4 . 4 6m E q
D . 2 5 . 0m E q a-:\

7 7. H o w r n a n y r' n E q ' so f s o d i u m i o n a r e t h e r e i n a l i t e r o f a 5 % s o l u t i o no f s o d i u mb i c a r b o n a t e ?
A t o m i c n u m b e r sa r e : N a = 2 3, H = 1 ,C = 1 2 ,0 = 1 6 .
A . 5 9 . 5m E q B ) 2 1 7 . 4m E q c ) 2 9 8 . 0m E q d ) 5 9 5 . 0m E q

2 8 . 5 0 m i l l i e q u i v a l e not f C a C l i2n j e c t i o nt o b e g i v e nt o a p a t i e n ta d m i t t e dt o t h e w a I d . C a l c u l a t e
t h e n u m b e r o f m g o f e l e m e n t a lc a l c i u mi n t h a t i n j e c t i o n .[ C aa t o m i cw e i g h t 4 0 ]
A. 1000mg
:{ !,
B. 500mg
C. 1O0mg
D . N o n eo f t h e a b o v e

2 9 . T h e m i l l i e q u i v a l e not f a m a g n e s i u mp h o s p h a t ei n j e c t i o n( 1 0 m 1 i)s 3 3 0 . T h e m m o l e o f t h a t
injection is expectedto be?
A. Higher ,'. ':
x,
B. Lower , ,, .,,
C. Same { *'
D . N o n eo f t h e a b o v e { : -- .'

3 0 . H o w m a n yg r a m so f o p i u mc o n t a i n i n g l 5 % o fom o r p h i n ea, n d h o w m a n yg r a m so f l a c t o s seh o u l db e

u s e dt o p r e p a r e1 5 0g o f p o w d e rc o n i a i n i n 1g 0 %w / w m o r p h i n e ?

C o p y r i g hAt 2 O O O - 2 0 T 12 I P SI n c .U n a u t h o r i z erde p r o d u c t i o o
n f t h i s m a n u a il s s t r i c t l yp r o h i b i t e da n d i t i s i ; l e g a l
t o r e p r o d u c ew i t h o u t p e r m i s s i o nT.h i sm a n u a il s b e i n gu s e dd u r i n gr e v i e ws e s s i o ncso n d u c t e db y P h a r m a c y -
Prep.
 www.pnarmacyprep.com

A. 10 g opium and 140g lactose

B . 1 5 g o p i u ma n d1 3 5g l a c t o s e
C. 50 g opium and 100g lactose
D. 100g opium and 50 g lactose
...
\i "
3 1 . P a t i e n tw a s a d m i t t e dt o E Ra n d w a s g i v e n K C Ii n j e c t i o n sa s 6 0 m g e v e r y 1 2 h o u r s f o r 3
d a y s .T h e p a t i e n tw a s t a k i n g 3 m l i n e a c h i n j e c t i o n .T h e l a b e lo f t h e i n j e c t i o ni s 6 0 m g / 3 m 1 .T h e
n u m b e r o f i n j e c t i o n st h e p a t i e n t r e c e i v e di s :
A) 3 B)4 c )s P6
3 2 . N u r s ew a n t s t o g i v e T P N 2 5 0 m l l . V .4 t i m e s d a i l yf o r 5 d a y st o c a n c e rp a t i e n t .T h e b o t t l e
h a s 5 0 0 m l s i z e .T h e n u m b e r o f b o t t l e su s e d w e r e :
A) s B) 10 c) 20 D) 7.s
'/,

3 3 . W h i c ho f t h e f o l l o w i n g?

H.'. O
, H
..;\-, -.y'--.- NF{:
f'
l_:_ _lJHaC
ri l ' . H, ,

A)amphetamine B ) p s e u d o e p h e d r i n e C )d e x t r o a m p h e t a m i nDe )m e t h y al m p h e t a m i n E
e)
cocaine

3 4 . S e r o t o n i (n5 H T i)ss y n t h e s i z ef rdo m t r y p t o p h a nt ,h i sc o n t a i ni n d o l er i n gw h i c hc a t a l y z etdo 5 -

h y d r o x yt r y p t o p h a n
b y t h e f o l l o w i n ge n z y m e :

IH
1UC\O
J U/ \
T" I
to-..a.-\_-lrr,
Aromaticamin
r > l l l ) aciddecarboxylSse
\Z-ru'
H

Tryptophan (5-HrP) Serotonin

(5-HT)

A - A r o m a t i ca m i n o a c i d d e c a r b o x y l a s e B - T r y p t o p h a nd e c a r b o x y l a s e

C-Tryptophan
hydroxylase D - l n d o l eh y d r o x y l a s e E - T r y p t o p h adne h y d r o x y l a s e

3 5 .T h ef o l l o w i n gs t r u c t u r ei s a p r o s t a g l a n dai nn a l o g u e sW, h a ti s c o r r e c t ?

C o p y r i g hAt 2 O O O - 2 0T 1 l.P
2 SI n c .U n a u t h o r i z erde p r o d u c t i o o
n f t h i s m a n u a li s s t r i c t i yp r o h i b i t e da n d i t i s i l l e g a l
t o r e p r o d u c ew i t h o u tp e r m i s s i o nT.h i sm a n u a il s b e i n gu s e dd u r i n gr e v i e ws e s s i o ncso n d u c t e db y P h a r m a c y -
Prep.
 www.pnarmacyprep.com

\_-cooH

A ) P r o s t a g l a n dGi na n a l o g u e s B ) P r o s t a g l a n dFi n
a n a l o g u e s C )P r o s t a g l a n dEi na n a l o g u e s D ) P r o s -
taglandin
I a n a l o g u e sE ) T h r o m b o x a n e 4 2

36. Indoleringis presentin all except?

A) serotonin B) Niacin C )M e l a t o n i n D) Leukotrienes E )s u m a t r i p t a n

37. What classof drug represents

the followingchemicalstructure?

o
l t s j-t c \ I
Y \ )
=
-
Yl
CH..
, L^ _
CO,H

A-Diuretics B-ACEi;riribitors C-Calciuinchannelblockers

D-SelectiveSerotoninReceptorinhibitors E) AngiotensinReceptorBlockers(ARBs)

38, Whichof thefollowing

drugsrepresent
thestructure
below?

H
* N r
n ri LJUr-:i
- I I
't i: ^ I
. i t l ' t ' . ;

i ri
I o,)._ o
l - t i
l - -.r - . t i
-ht,1
tYv-..

A- Leukotriene
antagonists B- Betablockers C - C o u m a r i n s D - C a l c i u mc h a n n e lb l o c k e r s

E -B e n z o d i a z e p i n e s

39. Sequencethe foliowing beruodiazepine starting from short acting to long acting: Diazepam,
Oxazepam,Triazolarn. clonazepam
A) Triazolam < Diazepam < Oxazepam< Clonazepam
p)'friazolam < Oxazepam < Clonazepam< Diazepam
C)'friazolam < Oxazepam < Diazepanr< Clonazcpam

C o p y r i g hAt 2 0 0 0 - 2 0 1T n f t h i s m a n u a li s s t r i c t l yp r o h i b i t e da n d i t i s i l l e g a l
2 I P SI n c .U n a u t h o r i z erde p r o d u c t i o o
to reproduce w i t h o u t p e r m i s s i o nT.h i sm a n u a il s b e i n gu s e dd u r i n gr e v i e ws e s s i o ncso n d u c t e db y P h a r m a c y -
Prep.
www-pnarmacyprep.com

D) Triazolam<Clonazepam<Oxazepam< Diazepam

4 0 .T h ef o l l o w i n gs t r u c t u r ei s l o v a s t a t i na, H M G - C A . h i c ho f t h e f o l l o w -
o r e d u c t a sien h i b i t o rW
i n g i st h e e s s e n t i af ol r i n h i b i t i n gH M G - C o A r e d u c t a saec t i o n

cH3cH2cH-c-o
^L-l
vr 13

LJ i/-
r l?v

Lovastatin

ring
AJ'Lactone B) 3,5 dihydroxycarboxylate C ) m e v a l o n i ca c i d D) ester E)bicyclicring

4 1 .T h ef o l l o w i n gs t r u c t u r e a n A n g i o t e n s irne c e p t o irn h i b i t o rW
islosartan . h a ti s i n c o r r e c t ?

/^-"/\Y'N'. .l
> l
l m i d a z o l er i n g( e s s e n t i a) tl = ; * 1

'l'ctra:to1e
ring
t I-OH
f/\
1.
i

N-N
N.
N
n
t -

Losartan

A ) l m i d a z o l er i n g i s e s s e n t i af lo r a n t i h y p e r t e n s i vaec t i o no f A R B s
B ) A R B sd o n o t c a u s ec o u g h s i d e e f f e c t
C ) A R B sa r e c o n t r a i n d i c a t e di n p r e g n a n c y
cough
D ) A R B sa r e t h e b e s t a l t e r n a t i v e sf o r t h o s e w h o d o n o t t o l e r a t eA C EI n h i b i t o ra s s o c i a t e d
Q A R B sd o N O T r
c a u s ea l l e r g i ce a c t i o l
n i k ea n g i o e d e m a

c a t i e n t sf ,o r e v e r y1 m g / k go f g e n t a m i c i an d m i n i s t e r e d ,
4 5 ) I n d o s i n gt h e d r u gg e n t a m i c iinn p e d i a t r i p
t o i n c r e a s be y 2 . 5V g / m l .W h a tw o u l db e t h e e x p e c t e sd e r u m
s e r u md r u gc o n c e n t r a t i o nasr e e x p e c t e d
d r u gc o n c e n t r a t i of no l l o w i n ga n a d m i n i s t r a t i oonf a Z . S @ k g d o s e o f g e n t a m i c i n ? :

A-5 ;rg/ml Y - 6 . 2 5g g / m l C-10prg/ml D - 2 . 5p g / m l , .-j

F
a . \
E -

C o p y r i g hOt 2 0 0 0 2 0 1 2T I P Sl n c .U n a u t h o r i z erde p r o d u c t i o on f t h i s m a n u a li s s t r i c t l yp r o h i b i t e da n d i t i s i l l e g a l
e i t h o u tp e r m i s s i o T
t o r e p r o d u cw nh. i sm a n u a il s b e i n gu s e dd u r i n gr e v i e ws e s s i o ncso n d u c t e d byPharmacy-
Prep.
 www.pharmacyprep.com
i
\.,
!\'
4 6 ) A n e l i x i r i s t o c o n t a i n 2 5 0 m g o f a n a l k a l o i d i n e a c h t e a s p o oHn of uwl m
d oasney.g r a m s o f t h e a l k a -
loidwill be requiredto prepare5 litresof the elixir?

A-0.25g B-5g C-250g D-2.5g

47) A pediatricproductcontains100mgof erythromycin in eachdropper(2.5m1)

ethylsuccinate of the
product.How manykilograms of erythromycin would be requiredto prepare5000
ethylsuccinate
pint-size
bottles?

A-74.6kg 8-84.6kg C-99.5kg D-94.6kg

4 8 ) A p h y s i c i a n p l a c e s a p a t i e n t o n a d a i l y d o s e o f 4 3 u n i t s o f U S 0 i n s u l i n ( 8H0ouwn m
i t sa/nmy Lm) l.
s h o u l dt h e p a t i e n it n j e c te a c hd a y ?

A-0.4 B-O.s " c-0.6 D-0.25

4 9 )A 2 0 - m l v i aol f b i o l o g i sc o l u t i o ni s l a b e l l e d
" 2 . 0m e g a u n i t s .H
" o w m a n yu n i t so f d r u ga r e p r e s e nitn
everyml of solution?

4-2000 8-1000 c-100,000 D-10,000

5 0 ) T h e u s u a l i n i t i a l d o s e o f c h l o r a m b u c i l i s l 5 0 1 r g p e r k g o f b o d y w e i g h tHoonwc m
e aadnayym. i l l i -
g r a m ss h o u l db e a d m i n i s t e r et o
d a p e r s o nw e i g h i n g1 5 4i b s . ?

4-10.5mg B-18mg C-15mg D-8mg

'tn
"t :. 'j r'
5 1 ) A n i n i t i a hl e p a r i nd o s eo f n o t l e s st h a n 1 5 0u n i t s / k go f b o d yw e i g h th a sb e e nr e c o m m e n d eodf o p e n -
h e a r ts u r g e r y .H o wm a n ym l o f a n i n j e c t i o n c o n t a i n i n5g0 0 0h e p a r i nu n i t sp e rm i l l i l i t esr h o u l db e
a d m i n i s t e r et do a , 3 0 0 - p o u npda t i e n t ?

A - 5 . 1p r t pl
B_4.1 C_5.m
1l D_4.1
ml
;
t:* :,
5 2 ) T h e p e d i a t r i c d o s e o f c e f a dirso3x0i lm g / k g / d a yl f. a c h i l d i s g i v e n a d a i l y d o s e o f 2 t e a s p o o n f u l o f a
suspension per 5 ml, what is the weightin lb. of the child?
containing rF of cefadroxil
1,r:
4 - 1 9 . 5l b s . 8 - 1 8 . 8l b s . _ _ C - 1 8l.b3s . D - 1 8 . 1l b s .

5 3 ) l f t h e l o a d i n gd o s eo f K a n a m y c i ns 7 m g / k go f b o d yw e i g h t h
, o w m a n yg r a m ss h o u l db e a d m i n i s -
teredto a patientweighing130 lbs.?

A-0.492g 8-0.414g C-414g D-0.485g

5 4 )T h ea d u l td o s eo f a l i q u i dm e d i c a t i o ins 0 . 1m l / k go f b o d yw e i g h ta s s i n g l ed o s e .H o wm a n yt e a -
spoonfulsshouldbe givento a patientweighing22.0lbs.?

A - 2t s p . B - 2 . 5t s p . C - 2t b s p . D - 2 . 5t b s p .

C o p y r i g h t @ 2 0 0 0 - 2 0 L 2T I P SI n c . U n a u t h o r i z e dr e p r o d u c t i o no f t h i s m a n u a l i s s t r i c t l y p r o h i b i t e da n d i t i s i l l e g a l
t o r e p r o d u c ew i t h o u t p e r m i s s i o n T
. h i s m a n u a l i s b e i n g u s e d d u r i n g r e v i e w s e s s i o n sc o n d u c t e d b y P h a r m a c y -
Prep.
 www.pnarmacyprep.com

s4)lf a prescription
orderrequires25 g of concentrated
HCI(density1,.189/ml),
what volumeshouldthe
p h a r m a c i smt e a s u r e ? \.
# l}r '..':'
a29.so mt 8-0.0212ml c-23.0ml D-27.2ml

s s i/the
) doseof a drugis 0.5mg/kgbodyweight/day,
how manymg willa 35lb infantreceiveper
24hours?

A-7.9mg B - 7 . 1m g C - 7 . 2m g D-7.4mg

56) What is the weightof 60 ml of oil whosedensityis 0.9624g/ml?

g B-57.7g
A-5.77O C-6.0g g
D-O.577

58)Aprescription callsfor 0.3 g of phosphoric acidwith a specificgravityof 1,.71..

How manymilliliters
s h o u l db e u s e di n c o m p o u n d i ntgh e p r e s c r i p t i o n ?

A-0.s B-0.7 c-0.18 D-0.3

5 9 ) H o w m a n y m L o f a s y r u p h a v i n ga s p e c i f i cg r a v i t yo f 1 . 3 5 0s h o u l d b e m i x e d w i t h 3 0 0 0 m L o f a s y r u p
?
h a v i n ga s p e c i f i cg r a v i t yo f L 2 5 0 t o o b t a i n a p r o d u c t * h a v i nag s p e c i f i cg r a v i t yo f 1 . 3 1 0 ?
g,i t:
4-3500 mL mL C - 4 6 0 0m L D - 5 5 0 0m L i ' lt ' ' :' :' l
,,.Y-.450O (, - S
l'? :
6 0 ) A p a t i e n ti s d e t e r m i n e dt o h a v e 0 . 8 m g o f g l u c o s ei n e a c h m i l l i l i t e ro f b l o o d . E x p r e s st h e c o n c e n t r a -
t i o n o f g l u c o s ei n t h e b l o o d a s m g % .

4-800 mg% B - 0 . 8m g % C-8mg% D-80mg%

6 1 ) H o w m a n y m L o f a 1 : 4 0 0 ( r v / v )s t o c ks o l u t i o ns h o u l d b e u s e dt o m a k e 4 l i t r e so f a 1 : 2 0 0 0( w / v ) s o l u -
/ ', , . '
t i o n? t , Y

A-1000m1 8 - 2 0 0m L C - 8 0 0m L D-1600m1

6 2 )f a p a t i e n it s d e t e r m i n e tdo h a v e1 0 0m g % o f b l o o dg l u c o s ew, h a t i s t h e e q u i v a l e ncto n c e n t r a t i ol n

i : ' .1 ' r : : ' t
termsof mg/dL? !l.l.i. iir
,, I
,i.
lr
* - '
" ' I 1 ! ' 1 ' 1 -
A-1 mg/dL B-10 mg/dL C - 4 0m g / d L D-100mgldL

. 5 3 ) S t r o n gl o d i n eS o l u t i o nU S Pc o n t a i n s 5 % w / v i o d i n e H o w m a n ym g o f i o d i n ea r e c o n s u m e d a i l yi f
t h e u s u a ld o s e i s 0 . 3 m L t . i . d . ?

A-1 \ mo R-QO nro C-22.5

mg D-45mg

6 4 ) E x p r e s si n p e r c e n t a g et h e f l u o r i d ec o n c e n t r a t i o ni n d r i n k i n gg i v e n i n 0 . 6 p p m

A 0.06% 8-0.00006% c-0.0006% D,0.006%

10
C o p y r i g hOt 2 0 0 0 - 2 0 1T2 I P SI n c .U n a u t h o r i z erde p r o d u c t i o o
n f t h i s m a n u a li s s t r i c t l yp r o h i b i t e da n d i t i s i l l e g a l
t o r e p r o d u cw
e i t h o u tp e r m i s s i o T
n .h i sm a n u ails b e i n gu s e dd u r i n gr e v i e w s e s s i o cnos n d u c t e bd y P h a r m a c y -
Prep.
 www.pnarmacyprep.com

65) How manygramsof dextroseare requiredto prepare4 litresof a 5%solution?

4-0.29 B-200g C-Le d-20g

6 6 ) H o w m a n yg r a m so f p e t r o l a t u m
s h o u l db e a d d e dt o 2 5 0 9o f a 2 5 %s u l p h u o
r i n t m e n t o m a k ea 5 %
ointment?
t i "
:
4-1000g 8-1250g C-500g D-100g

67) How manygramsof potassium

citrateare neededto prepare1 litreof 10%?

A-1000g B-50g C-100g D-10g

68) How manygramsof a drugare requiredto make120mL of a 25%solution?

A-30g B-10g C-12.0g D-12g :

69)CalciumH y d r o x i d e T o p i c a l S o l u tcioonnt a i n 1
s - 7 0m g o f c a l c i u mh y d r o x i d p
e e r 1 0 0m L a t l - 5 sC . E x -
pressthisconcentration as ratiostrength.

A-1:688 B-1:888 - C-1:588 D-1:788

70) How manymg of isofluorophate are containedin 15 g of a 1: 10,000ophthalmicsolutionof isofluro-

p h a t ei n p e a n u ot i l ? ' ', l'l

A-1.7mg B-1.9mg oAL*g C-1.8mg

\*--..-
71) A cupricchlorideinjection(0.4mg Cu/mL)is usedas an additiveto lV solutionfor TPN.What is the
final ratiostrengthof coppeiinthe fpirilolution if 2.5 mL of the injectionis addedto enoughof the
lV solutionto prepareSO*O_11? , .

A-1:500 8-1:5000 C-1:500,000 D-1:50,000

7 2 ) H o wm a n ym i l l i l i t r eosf a 2 3 . S % ( w / vc)o n c e n t r a toef S o d i u mC h l o r i d e

s o l u t i o ns h o u l db e u s e di n
preparing650 mL of a st6Ektilriion suchthat 30 mL dilutedto litrewillyielda 1: 5000solution?
'' :'t' '
t'
A - 0 . 2m L 8 - 4 . 3 3m L C-18.4m 4L D-11.75 mL

73) Youhavea stocksolutionof 50%Sodiumcitrateandyou werepskey' to prepare300 mL of a 1079*

' !'
s o l u t i o n .H o w m a n ym L i s n e e d e d ? . .,

A-20 B-15, . C-30 D-60

| ;'"'
7 4 ) H o w m a n ym i l l i l i t r eosf t : 1 6 s o l u t i o no f s o d i u mh y p o c h l o r i tseh o u l db e u s e di n p r e p a r i n 5g , 0 0 0m L
o f a 5 % s o l u t i o no f s o d i u m h y p o c h l o r i t ef o r i r r i g a t i o n ?

A 800 ml 8-2500 ml C - 4 0 0 0m l D-300ml

11
C o p y r i g hAt 2OOO-20T 12 I P SI n c .U n a u t h o r i z erde p r o d u c t i o o
n f t h i s m a n u a li s s t r i c t l yp r o h i b i t e da n d i t i s i l l e g a l
t o r e p r o d u c ew i t h o u t p e r m i s s i o nT.h i sm a n u a li s b e i n gu s e dd u r i n gr e v i e ws e s s i o ncso n d u c t e db y P h a r m a c y -
Prep.
 www.pharmacyprep.com
r-*
t' i
o '+' r-i') '
75) Prepare1000ml of KMnO+1: 12,000 compressesout of KMnO- ti ,pOO.
A - A d d 3 3 3 . 3m L waterto 1000mL KMnO+1: 8,000
B-Add 666.6mL rvaterto 333.3mL KMnOa i: 8.000
C - A d d3 3 3 . 3m L KMnO+ 1: 8.000and enough.uvater
to make U n a l v o l u m e1000rnl-
D-Add 333.3rnl- rvaterto 666.6mL KMnOo 1: 8.000

(w/v) concentrate
76) How manymillilitersof 24%o of salinesolutionshouldbe usedin preparing600 mL
o f a s o l u t i o ns u c ht h a t l O m L d i l u t e d
t o a l i t r ew i l l v i e l da O . O 9 %
solution? rr i

4-300ml B - 1 5 0m l C- 50.0
ml D-225m\
'
*;,-1

i s i n t h e f o r m o f t a b l e t se, a c hc o n t a i n i n5g. 0g . H o wm a n yt a b -
7 7 l f h e o n l ys o u r c eo f S o d i u mC h l o r i d e
letsshouldbe usedin preparing3000litresof a solutionof suchstrengthtfrfi.zd"mLdilutedto 100
mL with water will yielda 0.9%(w/v)solution? t .

A-60,000tablets tablets
-B-27,OO0 C-12,000
tablets D-9,000tablets

78) How manygramsof \O%(w/w) ammoniasolutioncan be madefrom 1800g of 28%(w/w) strong

ammonia
solution?

A-6428.57g 8-5040g g
C-50,400 D-642.86g

7 9 ) H o w m a n ym l o f O . 9 %( w / v )N a Csl o l u t i o ns h o u l db e p r e p a r e df r o m 2 5 0 m l o f 2 5 %( w / v )s o l u t i o n ?

4 - 3 7 5 0m l 8 - 2 5 0 0m l C - 6 9 4 4 .m
4l D - 9m l

8 0 ) A P h a r m a c yt e c h a d d s 7 5 m L o f s t r o n gi o d i n es o l u t i o nU S P(5.0%w/v) to 1 litreof sterilewater for

i r r i g a t i o n .W h a t i s t h e % w / v o f i o d i n ep r e s e n t ?

A-035% B-4.475oi,' c-0.53% D-0.60%

81) 30 g of hydrocorlisone preparejn 1'-1g rncntholand 1i4 g camphor?What is

cream19'0.
weight of mentholand camphorof each
a) ll4:0.25 g of eachmentholandcamphor;29.5g of hl,drocortisone crean]
b) 2.5 g of eachmentl-roland camphor;5 g of hydrocorlisonecrearn
c) 5 g of eachmentholand camphor: 20 g of hydrocortisone cream
D) 6.25 g cachmentholand camphor- 17 g of hydrocortisone crealr

L2
C o p y r i g hOt 2000-2012 T I P SI n c .U n a u t h o r i z e dr e p r o d u c t i o no f t h i s m a n u a l i s s t r i c t l yp r o h i b i t e da n d i t i s i l l e g a l
e i t h o u tp e r m i s s i o. Tn h i sm a n u a li s b e i n g u s e d d u r i n g r e v i e ws e s s i o n sc o n d u c t e db y P h a r m a c y
t o r e p r o d u cw
Prep.